SCHEMBL7145170

SCHEMBL7145170

Cc1cc(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)cc(Br)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.50
HTT P42858 2/20 0.46
KMT2A Q03164 4/20 0.44
POLB P06746 1/20 0.44
HSP90AA1 P07900 1/20 0.43
CXCR5 P32302 1/20 0.43
APLNR P35414 1/20 0.43
RAB9A P51151 1/20 0.43
CCR6 P51684 1/20 0.43
GFER P55789 1/20 0.43
MAPT P10636 1/20 0.43
HSD11B1 P28845 1/20 0.43
LMNA P02545 1/20 0.42
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA3 P07451 2/20 0.41
CA4 P22748 2/20 0.41
CA6 P23280 2/20 0.41
CA5A P35218 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141944 0.89 HTR6 (0.62) HTR6HTTKMT2APOLBHSP90AA1
SCHEMBL7137357 0.80 HTR6 (0.78) HTR6KMT2AHSP90AA1MAPTLMNA
SCHEMBL7141197 0.79 HTR6 (0.47) HTR6HTTKMT2APOLBHSP90AA1
SCHEMBL7137054 0.78 HTR6 (0.49) HTR6HTTKMT2APOLBHSD11B1
SCHEMBL7142883 0.76 ACHE (0.55) HTTKMT2APOLBHSP90AA1CXCR5
SCHEMBL7143678 0.76 AGTR1 (0.47) HTR6HTTKMT2APOLBHSP90AA1
SCHEMBL5864975 0.76 TSHR (0.48) HTTKMT2AMAPTLMNAACHE
SCHEMBL29664408 0.76 TSHR (0.48) HTTKMT2AMAPTLMNAACHE
SCHEMBL11419996 0.75 CA2 (0.67) HTTKMT2APOLBHSD11B1LMNA
SCHEMBL3158508 0.75 CA2 (0.67) HTTKMT2APOLBHSD11B1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0930302-B1 Benzosulfone derivatives HOFFMANN LA ROCHE (CH) 2003-04-02 EP disclosed
US-5990105-A POSSESS A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; TREATING OR PREVENTING PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, DEPRESSIONS, NEUROLOGICAL DISORDERS, PARKINSON'S, AMYOTROPHIC LATERAL SCLEROSIS, ALZHEIMER'S AND HUNTINGTON'S DISEASE HOFFMANN-LA ROCHE INC. (US) 1999-11-23 US disclosed
EP-0930302-A2 Benzosulfone derivatives F.HOFFMANN-LA ROCHE AG (CH) 1999-07-21 EP disclosed